News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Matteo Lambertini: Extremely honored and grateful for the chance to contribute to this important ASCO research statement on why and how to measure ovarian toxicity in clinical trials.
Photo taken from Matteo Lambertini/Twitter
Oct 7, 2023, 19:20

Matteo Lambertini: Extremely honored and grateful for the chance to contribute to this important ASCO research statement on why and how to measure ovarian toxicity in clinical trials.

Matteo Lambertini, Associate Professor at University of Genova, shared on Twitter:

“Extremely honored and grateful for the chance to contribute to this important ASCO research statement on why and how to measure ovarian toxicity in clinical trials: really hope this work can help improving the care of young women with cancer.”

Matteo Lambertini: Extremely honored and grateful for the chance to contribute to this important ASCO research statement on why and how to measure ovarian toxicity in clinical trials.

For the article click here.
Source: Matteo Lambertini/Twitter

ASCO cancer Matteo Lambertini OncoDaily Oncology
Special Coverage
Blog
May 7, 2025, 17:43
Hesham ElGhazaly Highlights Egypt-Algeria Collaboration in Cancer Control at Regional Summit
Blog
May 7, 2025, 17:20
Navigating Gavi: Supporting CSOs in Advancing Access to HPV Vaccination - UICC
Blog
May 7, 2025, 16:59
Happy National Nurses Week to Our Expert Infusion Nurses - Dana-Farber’s Breast Oncology Center
Blog
May 7, 2025, 16:37
ECO - Are you ready to support your young colleagues across Europe? 
Science
May 7, 2025, 16:29
Elie Dib: Talazoparib Confirmed Promising Activity in Solid Tumors With ATM Alterations
Science
May 7, 2025, 16:17
Mark Lewis: Fascinating discussion of bezoars at tumor board
Blog
May 7, 2025, 16:06
Isabel Mestres: I’m deeply honoured to have been elected to the 2025–2027 NCD Alliance Board of Directors
Blog
May 7, 2025, 15:53
Giuseppe Curigliano and Barbara Jereczek-Fossa have been elected to lead ESMO and ESTRO - IEO European Institute of Oncology
Blog
May 7, 2025, 15:14
Martín Igor Gómez-Randulfe: Happy to Share Our New Review on Evolving Treatment for Advanced EGFR Mutated NSCLC
Blog
May 7, 2025, 14:58
Susanna Fletcher Greer: New Discovery by V Foundation Grantee Reveals CD4 Cells as Bloodborne Tumor Killers
Blog
May 7, 2025, 14:49
Daniel Flora: Why Do We Wait Until After A Cancer is Diagnosed to Design These Plans?
Blog
May 7, 2025, 14:37
Naveen Pemmaraju: Wonderful meeting friends and colleagues at successful Think Tank 2025 Hematology Meeting